Home | Business News | Browse by Publication | B | Biotech Week

Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger.

Publication: Biotech Week
Publication Date: 04-NOV-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) and IntelliPharmaCeutics Ltd. ("IPC") are pleased to announce that shareholders of each company have approved the plan of arrangement and merger pursuant to which Vasogen will combine with IPC to continue as a publicly-traded entity to be called IntelliPharmaCeutics International Inc. IPC is a privately-held...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Week
Critical Alerts for Schlumberger, Merck, Deere, Delta, and AutoZone Re..., November 04, 2009
Sequans Powers Alvarion's BreezeMAX Extreme Product Line for Mobile Wi..., November 04, 2009
SMIC Adopts Cadence DFM Solutions for 65- and 45-Nanometer IP/Library ..., November 04, 2009
SMIC 2009 Technology Symposium Held in Shanghai., November 04, 2009
SemBioSys provides an update on Botaneco., November 04, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.